Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Ariana Resources (AAU) by Hot Stock Rockets in ShareProphets
- Avoid Ten Lifestyle Group (TENG) by Steve Moore in ShareProphets
- Avoid Biome Technologies (BIOM) by Steve Moore in ShareProphets
- Buy Aviva (AV.) by Harvey Jones in The Motley Fool
- Buy CMC Markets (CMCX) by Harvey Jones in The Motley Fool
- Buy ITV (ITV) by Simon Watkins in The Motley Fool
- Buy Legal & General Group (LGEN) by Simon Watkins in The Motley Fool
- Hold Vodafone Group (VOD) by DZ Bank
- Buy Premier Foods (PFD) by Jefferies
- Buy Intermediate Capital Group (ICG) by Deutsche Bank
- Overweight WH Smith (SMWH) by JP Morgan
- Outperform TT Electronics (TTG) by RBC Capital
- Buy International Consolidated Airlines Group SA (CDI) (IAG) by Goldman Sachs
- Neutral Dr. Martens (DOCS) by Goldman Sachs
- Buy Intermediate Capital Group (ICG) by Goldman Sachs
- Neutral Vistry Group (VTY) by JP Morgan
- Buy Babcock International Group (BAB) by Jefferies
- Buy Convatec Group (CTEC) by Jefferies
- Buy Altona Rare Earths (REE) by Hot Stock Rockets in ShareProphets
- Avoid Marks Electrical Group (MRK) by Steve Moore in ShareProphets
Verici DX (VRCI) Share Price
Health Care Sector
NOTE: This is based on 10 open tips for Verici DX (VRCI)
| Latest Bid : 2.75p | Latest Ask : 3.00p |
| High Today : 3.00p | Low Today : 2.77p |
| This Years High : 11.75p | This Years Low : 2.77p |
| Volume : 118,340 | MKT Cap : £6.97M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Verici DX (VRCI) Overview
Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.Verici DX (VRCI) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2024-10-11 14:50:00 11/10/2024 | 42.50% |
| Avoid | Steve Moore | Premium Only | 2024-02-14 16:05:00 14/02/2024 | 66.18% |
| Avoid | Steve Moore | Premium Only | 2023-11-15 14:35:00 15/11/2023 | 68.06% |
| Avoid | Steve Moore | Premium Only | 2023-07-20 16:25:00 20/07/2023 | 75.00% |
| Watch | Steve Moore | Premium Only | 2023-07-03 11:40:00 03/07/2023 | – |
Verici DX (VRCI) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 2.75p | Latest Ask : 3.00p |
| High Today : 3.00p | Low Today : 2.77p |
| This Years High : 11.75p | This Years Low : 2.77p |
| Volume : 118,340 | MKT Cap : £6.97M |
Verici DX Overview
Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Verici DX Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2024-10-11 14:50:00 11/10/2024 | 42.50% |
| Avoid | Steve Moore | Premium Only | 2024-02-14 16:05:00 14/02/2024 | 66.18% |
| Avoid | Steve Moore | Premium Only | 2023-11-15 14:35:00 15/11/2023 | 68.06% |
| Avoid | Steve Moore | Premium Only | 2023-07-20 16:25:00 20/07/2023 | 75.00% |
| Watch | Steve Moore | Premium Only | 2023-07-03 11:40:00 03/07/2023 | – |